Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Pancreatic cancer, adult × S 1 (combination) × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Stomach Neoplasms 123 Pancreatic Neoplasms 34 Esophageal Neoplasms 17 Colorectal Neoplasms 16 Biliary Tract Neoplasms 16 Esophageal Squamous Cell Carcinoma 11 Neoplasm Metastasis 10 Carcinoma, Non-Small-Cell Lung 7 Gastrointestinal Neoplasms 6 Cholangiocarcinoma 6 Colonic Neoplasms 5 Adenocarcinoma 5 Recurrence 4 Neoplasms 4 Nasopharyngeal Carcinoma 4 Head and Neck Neoplasms 4 Advanced Pancreatic Cancer 4 Advanced Gastric Cancer 4 Rectal Neoplasms 3 Gastric Adenocarcinoma 3 Gallbladder Neoplasms 3 Advanced Solid Tumors 3 Stage IV Gastric Cancer With Metastasis 2 NSCLC 2 Locally Advanced Pancreatic Cancer 2 Gastric Cancer Peritoneal Metastases 2 Carcinoma, Transitional Cell 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Bile Duct Neoplasms 2

Interventions

Gemcitabine 5 130-nm albumin-bound paclitaxel 3 nimotuzumab 2 Hematologic Tests 2 Albumin-Bound Paclitaxel 2 surufatinib 1 napabucasin 1 irinotecan sucrosofate 1 ensituximab 1 Taxes 1 S 1 (combination) 1 Radiofrequency Ablation 1 Paclitaxel 1 Oxaliplatin 1 Mass Screening 1 Leucovorin 1 Irinotecan 1 Fluorouracil 1 Blood Specimen Collection 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06584227 2025-12-08

ACPC

Jinling Hospital, China

Phase 2 Recruiting

Gastrointestinal

Pancreatic cancer, adult, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡